CliffBio
biologic

Elelyso

taliglucerase alfa

Loss of exclusivityMay 2024projected — 12-year biologic exclusivity estimate
CompanyPfizer Inc.

Drug detail

Brand nameElelyso
Active ingredienttaliglucerase alfa
Strength200UNITS
Dosage formFor Injection
RouteIntravenous
ModalityBiologic
FDA approvalMay 2012
Marketing statusRx

More from Pfizer Inc.

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.